{"id":"https://openalex.org/W2979441372","doi":"https://doi.org/10.1182/blood.v118.21.1479.1479","title":"DUSP6-Mediated Negative Feedback to Oncogenic Tyrosine Kinase Signaling Prevents Excessive Accumulation of ROS and Enables Leukemia Cell Survival","display_name":"DUSP6-Mediated Negative Feedback to Oncogenic Tyrosine Kinase Signaling Prevents Excessive Accumulation of ROS and Enables Leukemia Cell Survival","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W2979441372","doi":"https://doi.org/10.1182/blood.v118.21.1479.1479","mag":"2979441372"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v118.21.1479.1479","doi":"https://doi.org/10.1182/blood.v118.21.1479.1479","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.1479.1479","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061717752","display_name":"Seyedmehdi Shojaee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Seyedmehdi Shojaee","raw_affiliation_strings":["Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA,","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081605030","display_name":"Maike Buchner","orcid":"https://orcid.org/0000-0002-4196-096X","observed_orcids":["https://orcid.org/0000-0002-4196-096X"]},"institutions":[{"id":"https://openalex.org/I2801240073","display_name":"University Medical Center Freiburg","ror":"https://ror.org/03vzbgh69","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2801240073"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Maike Buchner","raw_affiliation_strings":["Hematology and Oncology, University Hospital Freiburg, Freiburg, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology and Oncology, University Hospital Freiburg, Freiburg, Germany,","institution_ids":["https://openalex.org/I2801240073"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020303646","display_name":"Huimin Geng","orcid":"https://orcid.org/0000-0001-5339-5446","observed_orcids":["https://orcid.org/0000-0001-5339-5446"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Huimin Geng","raw_affiliation_strings":["Institute of Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA,","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019770989","display_name":"Ari M. Melnick","orcid":"https://orcid.org/0000-0002-8074-2287","observed_orcids":["https://orcid.org/0000-0002-8074-2287"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ari Melnick","raw_affiliation_strings":["Department of Medicine, Weill Cornell Medical College, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Weill Cornell Medical College, New York, NY, USA,","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016550578","display_name":"Sigal Gery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sigal Gery","raw_affiliation_strings":["Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA,","institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075550603","display_name":"Jeffery D. Molkentin","orcid":"https://orcid.org/0000-0002-3558-6529","observed_orcids":["https://orcid.org/0000-0002-3558-6529"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]},{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffery Molkentin","raw_affiliation_strings":["Children's Hospital Medical Center, Howard Hughes Medical Institute, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital Medical Center, Howard Hughes Medical Institute, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247","https://openalex.org/I1344073410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082903377","display_name":"Harold Phillip Koeffler","orcid":"https://orcid.org/0000-0001-5839-9913","observed_orcids":["https://orcid.org/0000-0001-5839-9913"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip Koeffler","raw_affiliation_strings":["Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA,","institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050087793","display_name":"Markus M\u00fcschen","orcid":"https://orcid.org/0000-0002-6064-8613","observed_orcids":["https://orcid.org/0000-0002-6064-8613"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Markus Muschen","raw_affiliation_strings":["Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA,","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5016550578","https://openalex.org/A5019770989","https://openalex.org/A5020303646","https://openalex.org/A5061717752","https://openalex.org/A5075550603","https://openalex.org/A5081605030"],"corresponding_institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I1285204247","https://openalex.org/I1344073410","https://openalex.org/I161318765","https://openalex.org/I180670191","https://openalex.org/I2801240073","https://openalex.org/I4387153466"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.29983554,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"118","issue":"21","first_page":"1479","last_page":"1479"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dusp6","display_name":"DUSP6","score":0.9980000257492065},{"id":"https://openalex.org/keywords/negative-feedback-signaling","display_name":"negative feedback signaling","score":0.9559999704360962},{"id":"https://openalex.org/keywords/oncogenic-tyrosine-kinase","display_name":"oncogenic tyrosine kinase","score":0.9100000262260437},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.8999999761581421},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.9760000109672546},{"id":"https://openalex.org/keywords/leukemia-cell-survival","display_name":"leukemia cell survival","score":0.6830000281333923},{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.7580000162124634},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.5490000247955322},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.6859999895095825},{"id":"https://openalex.org/keywords/p27","display_name":"p27","score":0.6549999713897705},{"id":"https://openalex.org/keywords/arf","display_name":"ARF","score":0.7549999952316284},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6119999885559082},{"id":"https://openalex.org/keywords/cpg-methylation","display_name":"CpG methylation","score":0.7730000019073486},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.7940000295639038},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.6499999761581421},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.781000018119812},{"id":"https://openalex.org/keywords/leukemia-stem-cells","display_name":"leukemia stem cells","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C97920573","wikidata":"https://www.wikidata.org/wiki/Q17915102","display_name":"DUSP6","level":5,"score":0.6834332942962646},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6615023016929626},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5714048743247986},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5606776475906372},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5006492137908936},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.4960382878780365},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.46930673718452454},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.46650972962379456},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45524781942367554},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4373268783092499},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3730383515357971},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3288305699825287},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3239690661430359},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.24721655249595642},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.20410028100013733},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14705371856689453},{"id":"https://openalex.org/C178666793","wikidata":"https://www.wikidata.org/wiki/Q422476","display_name":"Phosphatase","level":3,"score":0.11906519532203674},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10770416259765625},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09638532996177673},{"id":"https://openalex.org/C389152","wikidata":"https://www.wikidata.org/wiki/Q6593007","display_name":"Protein phosphatase 2","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v118.21.1479.1479","doi":"https://doi.org/10.1182/blood.v118.21.1479.1479","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.1479.1479","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2045893112","https://openalex.org/W2979902949","https://openalex.org/W2035098778","https://openalex.org/W1916983144","https://openalex.org/W2280088569","https://openalex.org/W2075142980","https://openalex.org/W70819804","https://openalex.org/W2603057731","https://openalex.org/W2101326169","https://openalex.org/W4283329916"],"abstract_inverted_index":{"Abstract":[0,1],"1479":[2],"Background:":[3],"Negative":[4],"feedback":[5,27,82,310,572,587],"signaling":[6,28,83,311,573],"has":[7],"been":[8],"described":[9],"as":[10,578],"a":[11,85,194,313,436,530,579],"mechanism":[12],"to":[13,31,61,210,228,239,299,429,544,589,603,637],"prevent":[14],"oncogene-induced":[15],"senescence":[16,230,296],"in":[17,29,35,59,84,109,158,166,180,193,242,257,302,346,420,471,521,529,552,574],"RAS-driven":[18],"tumor":[19],"cells.":[20,260,352,417,468],"Here":[21],"we":[22,67,197,324],"studied":[23,386],"mechanisms":[24],"of":[25,80,88,113,137,145,169,191,233,255,264,281,320,341,355,366,377,389,438,457,460,474,479,518,526,532,555,584,592,595,598,609,635],"negative":[26,81,309,571,586],"response":[30,60],"oncogenic":[32,129],"tyrosine":[33,62,130,174,321,445,465,575],"kinases":[34],"solid":[36,91],"tumors":[37],"(EGFR,":[38],"Her2;":[39],"n=5),":[40],"myeloid":[41,93],"leukemia":[42,50,219,259,277,351,467,599],"(CML/BCR-ABL1,":[43],"AML/FLT3-ITD;":[44],"n=6)":[45],"and":[46,94,124,205,215,237,266,272,283,297,343,524,601],"B":[47,95,125,170,274,439],"cell":[48,96,171,275,344,440,442],"lineage":[49,97,276],"(Ph+":[51],"ALL/BCR-ABL1;":[52],"n=4).":[53],"Results:":[54],"Studying":[55],"gene":[56],"expression":[57,136],"changes":[58],"kinase":[63,131],"inhibitor":[64,330],"(TKI)":[65],"treatment,":[66],"found":[68],"that":[69,153,371,454,618],"the":[70,146,189,318,326,361,367,374,387,455,483,620],"DUSP6":[71,104,138,147],"(dual":[72],"specificity":[73],"phosphatase":[74],"6)":[75],"represents":[76,312,373],"an":[77],"integral":[78],"component":[79],"wide":[86],"array":[87],"malignancies":[89],"including":[90,400],"tumors,":[92],"leukemia.":[98],"As":[99,406,534],"shown":[100],"by":[101,549],"Western":[102],"blot,":[103],"protein":[105,262,279],"levels":[106,156,263,280],"are":[107,163,226,462],"high":[108,292],"all":[110,421,627],"10":[111],"cases":[112,423],"patient-derived":[114,414,477,615],"Ph+":[115,181,213,394,415,424,480,616],"ALL":[116,182,214,395,416,425,481,617],"studied.":[117],"By":[118],"contrast,":[119,419],"normal":[120,159,222],"pre-B":[121,160],"cells":[122,127,161,202,220,396,426],"(n=3)":[123],"lymphoma":[126,441],"lacking":[128],"activity":[132],"(n=4)":[133],"also":[134],"lack":[135],"protein.":[139],"A":[140],"comprehensive":[141],"CpG":[142,154],"methylation":[143,155],"analysis":[144],"promoter":[148],"region":[149],"(HELP":[150],"assay)":[151],"revealed":[152,252],"observed":[157],"(n=12)":[162],"significantly":[164,286],"increased":[165],"various":[167],"types":[168],"lymphomas":[172],"(No":[173,444],"kinase;":[175,184,446],"n=68)":[176],"but":[177,348],"drastically":[178],"reduced":[179],"(BCR-ABL1":[183],"n=83;":[185],"p=0.013).":[186],"To":[187,305,469],"study":[188],"role":[190],"Dusp6":[192,327,380,461,610],"genetic":[195],"experiment,":[196],"transformed":[198],"bone":[199],"marrow":[200],"progenitor":[201],"from":[203,397],"Dusp6\u2212/\u2212":[204,218,258,273,350],"Dusp6+/+":[206,271,347],"mice":[207],"with":[208,291,403,499,547,626],"BCR-ABL1":[209],"model":[211],"human":[212],"CML.":[216],"While":[217,261],"show":[221],"growth":[223],"kinetics,":[224],"they":[225],"prone":[227],"cellular":[229,295,604],"(11-fold":[231],"increase":[232],"\u03b2-galactosidase+":[234],"cells;":[235],"p=0.0001)":[236],"fail":[238],"form":[240,300],"colonies":[241,301],"methylcellulose":[243],"(p=0.0002).":[244],"Strikingly,":[245],"flow":[246],"cytometry":[247],"staining":[248],"using":[249],"DCF":[250],"dye":[251],"drastic":[253],"accumulation":[254,340,591],"ROS":[256,293,342],"p27":[265],"Arf":[267],"were":[268,285,427,486,495],"similar":[269],"between":[270],"cells,":[278],"p53":[282],"p21":[284],"increased,":[287],"which":[288,623],"is":[289,357,382,611],"consistent":[290],"levels,":[294],"failure":[298],"methyl":[303],"cellulose.":[304],"test":[306,470],"whether":[307],"Dusp6-mediated":[308],"potential":[314],"therapeutic":[315,581],"target":[316],"for":[317,464],"treatment":[319,431,625],"kinase-driven":[322,466,576],"leukemias,":[323],"tested":[325],"small":[328],"molecule":[329],"2-benzylidene-3-(cyclohexylamino)-1-Indanone":[331],"hydrochloride":[332],"(BCI).":[333],"At":[334],"3":[335],"umol/l,":[336],"BCI":[337,356,390,430,448,510,519,562],"induces":[338],"significant":[339,451,553],"death":[345],"not":[349],"The":[353],"effect":[354,388,412,539],"dependent":[358],"on":[359,391,413,540,614],"Ncf1,":[360],"regulatory":[362],"cytosolic":[363],"p47":[364],"subunit":[365],"NAPH":[368],"oxidase,":[369],"suggesting":[370],"ROS-accumulation":[372],"main":[375],"pathway":[376],"cytotoxity":[378],"when":[379],"function":[381],"inhibited.":[383],"We":[384],"next":[385],"patient":[392],"derived":[393],"five":[398],"patients,":[399],"two":[401,476],"patients":[402],"T315I":[404,484,621],"mutation.":[405],"expected,":[407,535],"Imatinib":[408],"had":[409,449,537],"no":[410,450,538],"measurable":[411],"In":[418,435],"5":[422],"sensitive":[428],"(IC50":[432],"2.8":[433],"umol/l).":[434],"panel":[437],"lines":[443],"n=11),":[447],"effect,":[452],"indicating":[453],"effects":[456],"pharmacological":[458,607],"inhibition":[459,608],"selective":[463],"vivo":[472],"efficacy":[473],"BCI,":[475,548],"samples":[478],"carrying":[482],"mutation":[485],"xenografted":[487],"into":[488],"sublethally":[489],"irradiated":[490],"NOD/SCID":[491],"recipient":[492],"mice.":[493],"Mice":[494],"treated":[496],"ten":[497],"times":[498],"either":[500],"vehicle,":[501],"75":[502],"mg/kg":[503,509],"Nilotinib":[504,564],"(oral":[505],"gavage)":[506],"or":[507],"25":[508],"(via":[511],"tail":[512,527],"vein":[513],"injection).":[514],"Repeated":[515],"intravenous":[516],"injection":[517],"results":[520],"local":[522],"toxicity":[523],"necrosis":[525],"tissue":[528],"number":[531],"cases.":[533],"Nilotinib-treatment":[536],"overall":[541,556],"survival":[542,557],"compared":[543],"vehicle.":[545],"Treatment":[546],"contrast":[550],"resulted":[551],"prolongation":[554],"(BCI":[558],"vs":[559,563],"vehicle":[560],"p=0.008;":[561],"p=0.01).":[565],"Conclusion:":[566],"Our":[567],"studies":[568],"identify":[569],"DUSP6-mediated":[570,585],"leukemias":[577],"novel":[580],"target.":[582],"Inactivation":[583],"leads":[588],"massive":[590],"ROS,":[593],"activation":[594],"p53,":[596],"loss":[597],"self-renewal":[600],"propensity":[602],"senescence.":[605],"Importantly,":[606],"equally":[612],"active":[613],"carry":[619],"mutation,":[622],"evades":[624],"currently":[628],"available":[629],"TKI.":[630],"Disclosures:":[631],"No":[632],"relevant":[633],"conflicts":[634],"interest":[636],"declare.":[638]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-10-18T00:00:00"}